188
Participants
Start Date
August 30, 2022
Primary Completion Date
July 10, 2025
Study Completion Date
July 10, 2025
DKN-01
30 minute IV infusion (400mg) every two weeks with an additional loading dose in the first cycle of treatment
FOLFIRI
90-min IV infusion of irinotecan, leucovorin, and fluorouracil followed by a continuous 46-hour infusion of fluorouracil every two weeks
Bevacizumab
90-min IV infusion (5mg)
FOLFOX
2 hour IV infusion of oxaliplatin, folinic acid, and fluorouracil followed by a continuous 46-hour infusion of fluorouracil every two weeks
New York University, New York
Cornell University, New York
Mount Sinai Medical Center - New York, New York
White Plains Hospital, White Plains
Northwell Health, Lake Success
Center for Cancer and Blood Disorders, Bethesda
Wake Forest University, Winston-Salem
Duke University Medical Center, Durham
Messino Cancer Centers, Asheville
Prisma Health Cancer Institute - Faris, Greenville
Florida Cancer Specialists & Research Institute, Fleming Island
Florida Cancer Specialists & Research Institute, Gainesville
Miami Cancer Institute, Miami
Florida Cancer Specialists & Research Institute, Wellington
Florida Cancer Specialists & Research Institute (FCS), Cape Coral
SCRI Oncology Partners, Nashville
Tennessee Oncology, Nashville
Tennessee Oncology, Chattanooga
University of Wisconsin Hospital and Clinics, Madison
Sanford Cancer Center, Sioux Falls
Oncology Hematology Associates - Springfield, Springfield
Hematology Oncology Clinic, Baton Rouge
The University of Arizona Cancer Center, Tucson
UCLA, Los Angeles
MultiCare Tacoma General Hospital, Tacoma
Universitaetsklinikum Hamburg-Eppendorf (UKE) - Universitaeres Cancer Center Hamburg (UCCH), Hamburg
Universitaetsklinikum Heidelberg (UKHD) - Nationales Centrum fuer Tumorerkrankungen Heidelberg (NCT), Heidelberg
SLK-Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen - Klinik fuer Innere Medizin III, Heilbronn
Gemeinschaftspraxis fuer Haematologie und Onkologie - Magdeburg, Magdeburg
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz, Mainz
Dong-A University Medical Center, Busan
Kyungpook National University Chilgok Hospital, Daegu
Gachon University Gil Medical Center, Incheon
Inha University Hospital, Incheon
CHA University - Bundang CHA General Hospital, Seongnam-si
Seoul National University Bundang Hospital, Seongnam-si
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Seoul National University Hospital, Seoul
The Catholic University of Korea - St. Vincent's Hospital, Suwon
Lead Sponsor
Leap Therapeutics, Inc.
INDUSTRY